Boston Free Cash Flow Per Share from 2010 to 2024

BSX Stock  USD 72.91  3.92  5.68%   
Boston Scientific Free Cash Flow Per Share yearly trend continues to be fairly stable with very little volatility. Free Cash Flow Per Share is likely to outpace its year average in 2024. Free Cash Flow Per Share is the amount of cash Boston Scientific Corp generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share. View All Fundamentals
 
Free Cash Flow Per Share  
First Reported
2010-12-31
Previous Quarter
1.17205781
Current Value
1.23
Quarterly Volatility
0.36536274
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Boston Scientific financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Boston main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.3 B, Interest Expense of 193.9 M or Selling General Administrative of 5.2 B, as well as many exotic indicators such as Price To Sales Ratio of 4.58, Dividend Yield of 3.0E-4 or PTB Ratio of 5.87. Boston financial statements analysis is a perfect complement when working with Boston Scientific Valuation or Volatility modules.
  
This module can also supplement Boston Scientific's financial leverage analysis and stock options assessment as well as various Boston Scientific Technical models . Check out the analysis of Boston Scientific Correlation against competitors.

Latest Boston Scientific's Free Cash Flow Per Share Growth Pattern

Below is the plot of the Free Cash Flow Per Share of Boston Scientific Corp over the last few years. It is the amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share. Boston Scientific's Free Cash Flow Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Boston Scientific's overall financial position and show how it may be relating to other accounts over time.
Free Cash Flow Per Share10 Years Trend
Slightly volatile
   Free Cash Flow Per Share   
       Timeline  

Boston Free Cash Flow Per Share Regression Statistics

Arithmetic Mean0.66
Coefficient Of Variation55.31
Mean Deviation0.28
Median0.74
Standard Deviation0.37
Sample Variance0.13
Range1.2343
R-Value0.62
Mean Square Error0.09
R-Squared0.39
Significance0.01
Slope0.05
Total Sum of Squares1.87

Boston Free Cash Flow Per Share History

2024 1.23
2023 1.17
2022 0.64
2021 0.93
2020 0.8
2019 0.99
2018 -0.004345

About Boston Scientific Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Boston Scientific income statement, its balance sheet, and the statement of cash flows. Boston Scientific investors use historical funamental indicators, such as Boston Scientific's Free Cash Flow Per Share, to determine how well the company is positioned to perform in the future. Although Boston Scientific investors may use each financial statement separately, they are all related. The changes in Boston Scientific's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Boston Scientific's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Boston Scientific Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Boston Scientific. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Free Cash Flow Per Share 1.17  1.23 

Pair Trading with Boston Scientific

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Boston Scientific position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boston Scientific will appreciate offsetting losses from the drop in the long position's value.

Moving together with Boston Stock

  0.69HQY HealthEquity Financial Report 3rd of June 2024 PairCorr

Moving against Boston Stock

  0.91SINT SINTX TechnologiesPairCorr
  0.8RSLS ReShape LifesciencesPairCorr
  0.74BBLG Bone Biologics Corp Financial Report 20th of May 2024 PairCorr
  0.73HCAT Health Catalyst Upward RallyPairCorr
  0.72HSDT Helius Medical Techn Financial Report 9th of May 2024 PairCorr
The ability to find closely correlated positions to Boston Scientific could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Boston Scientific when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Boston Scientific - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Boston Scientific Corp to buy it.
The correlation of Boston Scientific is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Boston Scientific moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Boston Scientific Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Boston Scientific can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Boston Scientific Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Boston Scientific's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Boston Scientific Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Boston Scientific Corp Stock:
Check out the analysis of Boston Scientific Correlation against competitors.
You can also try the Stocks Directory module to find actively traded stocks across global markets.

Complementary Tools for Boston Stock analysis

When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Commodity Directory
Find actively traded commodities issued by global exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Is Boston Scientific's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boston Scientific. If investors know Boston will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Boston Scientific listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
2.856
Earnings Share
1.07
Revenue Per Share
9.8
Quarterly Revenue Growth
0.149
Return On Assets
0.0447
The market value of Boston Scientific Corp is measured differently than its book value, which is the value of Boston that is recorded on the company's balance sheet. Investors also form their own opinion of Boston Scientific's value that differs from its market value or its book value, called intrinsic value, which is Boston Scientific's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Boston Scientific's market value can be influenced by many factors that don't directly affect Boston Scientific's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Boston Scientific's value and its price as these two are different measures arrived at by different means. Investors typically determine if Boston Scientific is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boston Scientific's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.